US and Brazil move into ‘final stages’ of approving GE trees for commercial growing

fd dabb

The U.S. and Brazilian governments are moving into the final stages of weighing approval for the commercialisation of genetically engineered eucalyptus trees, moves that would mark the first such permits anywhere in the world.

The Brazilian government is slated to start taking public comments on such a proposal during the first week of September. Similarly, U.S. regulators have been working on an environmental impact assessment since early last year, a highly anticipated draft of which is expected to be released any day. While the United States has thus far approved the use of two genetically modified fruit trees, the eucalyptus is the first GE forest tree to near release. Similar policy discussions are currently taking place in the European Union, Australia and elsewhere, while China has already approved and is using multiple GE trees.

A key argument from ArborGen and others in favour of genetically engineered trees, and the plantation system more generally, is that increased use of “farmed” trees would reduce pressure on native forests. Indeed, ArborGen’s motto is “More Wood. Less Land”. Yet as the world has increasingly adopted the plantation approach, the impact has been clear. Indonesia, for instance, has allowed for the clear-cutting of more than half of its forests over the past half-century, driven particularly by the growth of palm plantations.

Read the full, original article: U.S., Brazil nearing approval of genetically engineered trees

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-14-at-11.11.06-AM
‘Turbo cancer’ or mRNA cancer cure? Strategies to counter misinformation
ChatGPT Image May 28, 2026, 08_16_38 PM
Viewpoint: Why the EPA mismeasures cancer risk of chemicals and what should be done to fix it
fda_logo_decimated
Viewpoint: RFK, Jr.’s FDA is on a screaming downward path—and why it may never recover
edb7f6d7-2370-418f-9578-74e29678e35c
Facts & Fallacies Podcast: Nicotine vaping—public health miracle, or risk to children? Professor Cliff Douglas
ChatGPT-Image-May-22-2026-10_56_42-AM-2
‘It’s not super useful’: As wariness about AI grows, Trump proposes rollback of healthcare safeguards
ChatGPT-Image-May-22-2026-10_26_09-AM
Gutting the National Science Board: How the Trump-RFK, Jr. crusade is erasing the separation of science and state
ChatGPT-Image-May-28-2026-11_31_47-AM-2
Relying on your doctor or AI miracle cure, death and debilitation? Neurologist makes the wrong choice
Screenshot-2026-05-27-at-10.51.25-AM
Viewpoint: ‘Monsanto’ blues—Planned Netflix movie promises yet another round of anti-glyphosate disinformation
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-May-26-2026-11_51_01-AM
Viewpoint: RFK, Jr.’s ‘sadistic’ solution to autism, depression, and other ills looks a lot like prison camp
Picture1
The Orange Bowl without oranges: Can CRISPR save Florida citrus?
vax-misinformation-main
Facts & Fallacies Podcast: Limit free speech to blunt social media misinfo?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.